SHETZLINE MICHAEL (CMO, SVP & Head of Drug Devt.) made both purchases and sales at IRONWOOD PHARMACEUTICALS INC
Purchased 3.4% of their position (17.01K shares) and sold 2.8% of their position (15.57K shares) — review individual transaction dates and prices for directional context.
P · 1S · 1
Filed: 2/25/2026ACC: 0001193125-26-071503
Officer· CMO, SVP & Head of Drug Devt.
Since Apr 2020
+1.44K
Net shares
Net buyer
$59.3K
Total sold
2
Open market trades
1B · 1S
2
Total transactions
17.01K acquired · 15.57K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−15.57K
Price / share
$3.81
Trade value
$59.32K
% of position
2.8%
2/23/2026
554.01K→538.44K
Common Stock
Direct
Shares
+17.01K
Price / share
$3.66
Trade value
$62.26K
% of position
3.4%
2/24/2026
504.41K→521.42K
Total
Net shares
+1.44K
Net value
$2.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/23/2026 | S · Sale | −15.57K | $3.81 | $59.32K | 2.8% | 554.01K | 538.44K |
| Common Stock Direct | 2/24/2026 | S · Sale | +17.01K | $3.66 | $62.26K | 3.4% | 504.41K | 521.42K |
| Total | +1.44K | $2.94K | ||||||
Derivative Transactions0
No derivative transactions reported